Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Xenoport (XNPT) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 447,590
  • Shares Outstanding, K 63,520
  • Annual Sales, $ 41,160 K
  • Annual Income, $ -82,310 K
  • 36-Month Beta 1.94
  • Price/Sales 10.87
  • Price/Book 56.52
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.21
  • Most Recent Earnings -0.23 on 05/05/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.96 +1.58%
on 06/13/16
7.07 unch
on 07/05/16
unch (unch)
since 06/03/16
3-Month
3.90 +81.28%
on 05/12/16
7.10 -0.42%
on 06/01/16
+2.22 (+45.77%)
since 04/05/16
52-Week
3.35 +111.04%
on 09/30/15
7.86 -10.05%
on 08/04/15
+0.75 (+11.87%)
since 07/02/15

Most Recent Stories

More News
Lifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc., LinkedIn Corporation, Mines Management, Inc., Rose Rock Midstream, L.P., STAAR Surgical Company, XenoPort, Inc. and Your Community Bankshares, Inc.

Exterran Corporation (EXTN) Lifshitz & Miller announces investigation on behalf of Exterran investors. Specifically, on April 26, 2016, Exterran announced it will restate its consolidated and combined...

Arbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period

Arbor Pharmaceuticals, LLC ("Arbor") and XenoPort, Inc. ("XenoPort") (NASDAQ:XNPT) announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act...

Addiction Therapeutics Development Pipeline Review, H2 2015

Research and Markets (http://www.researchandmarkets.com/research/m28s26/addiction) has announced the addition of the "Addiction - Pipeline Review, H2 2015" report to their offering. This report provides...

Biotechnology Equity Movers and Shakers -- Agenus, Xenoport, Akebia Therapeutics, and Northwest Biotherapeutics

NEW YORK, NY / ACCESSWIRE / January 11, 2016 / Park Lane Advisor has initiated coverage on the following equities: Agenus Inc. (NASDAQ: AGEN), Xenoport Inc. (NASDAQ: XNPT), Akebia Therapeutics Inc. (NASDAQ:...

Healthcare Sector Equities Under the Scanner -- Xenoport, Tetraphase Pharma, uniQure, and Spectrum Pharma

NEW YORK, NY / ACCESSWIRE / December 29, 2015 / Park Lane Advisor has initiated coverage on the following equities: Xenoport Inc. (NASDAQ: XNPT), Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH), uniQure...

Market Influences That Drive Equities Forward - New Research on Linn Energy LLC, Xenoport, Aratana Therapeutics, and Sify Technologies

NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Linn Energy...

BUYINS.NET: PHH, XNPT, CVCY, PBE, ATRC, ACHN Are Seasonally Ripe To Go Up In the Next Five Weeks

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of PHH Corp (NYSE:PHH), Xenoport Inc (NASDAQ:XNPT), Central Valley Community Bancorp (NASDAQ:CVCY), Powershares Dynamic Biotechnology and...

Stock Updates on Biotechnology -- Xenoport, Progenics Pharma, Ocata Therapeutics, and Vanda Pharma

NEW YORK, NY / ACCESSWIRE / December 17, 2015 / Park Lane Advisor has initiated coverage on the following equities: Xenoport Inc. (NASDAQ: XNPT), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Ocata Therapeutics...

11.8% Return Seen to Date on SmarTrend XenoPort Call (XNPT)

SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on October 12th, 2015 at $5.10. In approximately 2 months, XenoPort has returned 11.76% as of today's recent price of $5.70.

Market Influences That Drive Equities Forward - Complementary Research on EnerNOC, Fogo De Chao, Aegion, and Xenoport

NEW YORK, NY / ACCESSWIRE / December 14, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: EnerNOC Inc....

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.

See More

Support & Resistance

2nd Resistance Point 7.10
1st Resistance Point 7.09
Last Price 7.07
1st Support Level 7.04
2nd Support Level 7.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.